Stockscreener 앱 받기
68.06
0.19%
0.13
Hologic Inc 주식(HOLX)의 최신 뉴스
Stock Analysis | Hologic OutlookMixed Signals Amid Sector Volatility - AInvest
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? - The Globe and Mail
RadNet hires Hologic, Bausch + Lomb alum Jane Mazur - Medical Marketing and Media
Hologic's Diagnostics Arm Set For Long-Term Upside: What's Behind It? - Barchart.com
RBC Capital Reiterates Buy Rating for Hologic with $87 Price Target - AInvest
RBC Capital Upgrades Hologic (HOLX) to Outperform with Raised Pr - GuruFocus
Hologic’s Growth Story Looks Set For A Comeback - Finimize
Forecasting the Future: Next-Generation Biopsy-Based Cancer - openPR.com
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? - The Globe and Mail
Should You Buy, Sell Or Hold Hologic Stock Post Q3 Earnings? - Barchart.com
Hpv And Pap Testing Market Generated Opportunities, Future - openPR.com
RBC Capital Upgrades Hologic to Outperform From Sector Perform, Adjusts PT to $87 From $72 - MarketScreener
RBC Capital upgrades Hologic stock to Outperform on expected growth By Investing.com - Investing.com Canada
RBC Capital upgrades Hologic stock to Outperform on expected growth - Investing.com
Molecular Diagnostics Market Expands with Infectious Disease - openPR.com
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
Analysts Have Made A Financial Statement On Hologic, Inc.'s (NASDAQ:HOLX) Third-Quarter Report - simplywall.st
Why Hologic (HOLX) is a Top Value Stock for the Long-Term - Yahoo Finance
Interpreting Hologic (HOLX) International Revenue Trends - Yahoo Finance
What are analysts’ price targets for Hologic Inc. in the next 12 monthsMassive portfolio appreciation - Jammu Links News
Is Hologic Inc. a good long term investmentIdentify winners with top-tier analysis - Jammu Links News
Hologic, Inc. (NASDAQ:HOLX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - 富途牛牛
Hologic's Q3 Earnings Beat and Strategic Innovations: A Convincing Case for Value Investors - AInvest
Hologic Analyst Estimates: Third-Quarter Report Recap - AInvest
Analyst Estimates: Here's What Brokers Think Of Hologic, Inc. (NASDAQ:HOLX) After Its Third-Quarter Report - Yahoo Finance
What makes Hologic Inc. stock price move sharplyFree Predictions - Jammu Links News
What are Hologic Inc. company’s key revenue driversAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Hologic Inc. stockCapitalize on emerging market opportunities - Jammu Links News
Is Hologic Inc. stock overvalued or undervaluedIdentify safe investments with exceptional yields - Jammu Links News
What institutional investors are buying Hologic Inc. stockSpectacular growth rates - Jammu Links News
How does Hologic Inc. compare to its industry peersMaximize returns with strategic trading plans - Jammu Links News
Published on: 2025-08-03 05:06:54 - Jammu Links News
Hologic targets mid-single-digit organic revenue growth in 2026 as Breast Health rebounds and tariff mitigation advances - MSN
What is the risk reward ratio of investing in Hologic Inc. stockGet timely alerts on top market movers - Jammu Links News
Hologic, Inc. (NASDAQ:HOLX) Q3 2025 Earnings Call Transcript - Insider Monkey
Hologic’s Earnings Call: Strong Q3 Performance and Optimism - The Globe and Mail
Hologic Reports Strong Q3 2025 Earnings, Exceeds Guidance - MSN
BioZorb Lawsuit and Settlement Information: August 2025 - AboutLawsuits.com
Hologic (HOLX) Gets a Buy from J.P. Morgan - The Globe and Mail
Hologic 2025 Q3 Earnings Beats Expectations as Net Income Grows 0.2% - AInvest
Hologic, Inc. shares fall 1.53% after-hours following Morgan Stanley's price target adjustment to $69. - AInvest
Real time scanner hits for Hologic Inc. explainedExit Ready Momentum Stock Watchlist Expanded - metal.it
Mizuho raises Hologic stock price target to $75 on strong quarterly results - Investing.com Canada
Hologic (HOLX) Sees Updated Analyst Ratings and Price Targets | - GuruFocus
How did Oolong Pharmaceutical's revenue and expenses trend in Q4 2024? - AInvest
1.58%
자본화:
|
볼륨(24시간):